Selection and expansion of natural killer cells for NK cell-based immunotherapy

Natural killer (NK) cells have been used in several clinical trials as adaptive immunotherapy. The low numbers of these cells in peripheral blood mononuclear cells (PBMC) have resulted in various approaches to preferentially expand primary NK cells from PBMC. While some clinical trials have used the...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Petra S. A., Suck, Garnet, Nowakowska, Paulina, Ullrich, Evelyn, Seifried, Erhard, Bader, Peter, Tonn, Torsten, Seidl, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Symposium-in-Writing Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826432/
https://www.ncbi.nlm.nih.gov/pubmed/26810567
http://dx.doi.org/10.1007/s00262-016-1792-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826432/
https://www.ncbi.nlm.nih.gov/pubmed/26810567
http://dx.doi.org/10.1007/s00262-016-1792-y

Ejemplares similares